Literature DB >> 15754175

Cholinergic cortical circuits in Parkinson's disease and in progressive supranuclear palsy: a transcranial magnetic stimulation study.

Raffaele Nardone1, Igor Florio, Piergiorgio Lochner, Frediano Tezzon.   

Abstract

To investigate the involvement of the cortical cholinergic system in patients with Parkinson's disease (PD) and with progressive supranuclear palsy (PSP), we performed a comparative study of the short latency afferent inhibition (SAI) in ten patients with PD, in eight patients with PSP and in 15 healthy subjects. Six of the PD patients and four of the PSP patients had dementia. SAI was significantly increased in the PD patients, whereas it was not significantly different between PSP patients and the normal controls. Our findings demonstrate that the excitability of the motor cortex is differentially modulated by sensory afferents in PD and PSP and may indicate that the mechanisms of cholinergic dysfunction are different between the two diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15754175     DOI: 10.1007/s00221-005-2228-7

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  22 in total

1.  Normal or enhanced short-latency afferent inhibition in Parkinson's disease?

Authors:  Vincenzo Di Lazzaro; Antonio Oliviero; Fabio Pilato; Eleonora Saturno; Michele Dileone; Anna Rita Bentivoglio; Pietro A Tonali
Journal:  Brain       Date:  2004-04       Impact factor: 13.501

Review 2.  'Subcortical dementia': the neuropsychological evidence.

Authors:  R G Brown; C D Marsden
Journal:  Neuroscience       Date:  1988-05       Impact factor: 3.590

3.  Dopaminergic and cholinergic lesions in progressive supranuclear palsy.

Authors:  M Ruberg; F Javoy-Agid; E Hirsch; B Scatton; R LHeureux; J J Hauw; C Duyckaerts; F Gray; A Morel-Maroger; A Rascol
Journal:  Ann Neurol       Date:  1985-11       Impact factor: 10.422

4.  Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria.

Authors:  S J Collins; J E Ahlskog; J E Parisi; D M Maraganore
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-02       Impact factor: 10.154

5.  Brain muscarinic receptors in progressive supranuclear palsy and Parkinson's disease: a positron emission tomographic study.

Authors:  M Asahina; T Suhara; H Shinotoh; O Inoue; K Suzuki; T Hattori
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-08       Impact factor: 10.154

6.  Heterogeneity of cognitive impairment in progressive supranuclear palsy, Parkinson's disease, and Alzheimer's disease.

Authors:  B Pillon; B Dubois; F Lhermitte; Y Agid
Journal:  Neurology       Date:  1986-09       Impact factor: 9.910

7.  Differential regulation of molecular subtypes of muscarinic receptors in Alzheimer's disease.

Authors:  D D Flynn; G Ferrari-DiLeo; D C Mash; A I Levey
Journal:  J Neurochem       Date:  1995-04       Impact factor: 5.372

8.  Loss of pedunculopontine neurons in progressive supranuclear palsy.

Authors:  R M Zweig; P J Whitehouse; M F Casanova; L C Walker; W R Jankel; D L Price
Journal:  Ann Neurol       Date:  1987-07       Impact factor: 10.422

9.  Altered muscarinic and nicotinic receptor densities in cortical and subcortical brain regions in Parkinson's disease.

Authors:  K W Lange; F R Wells; P Jenner; C D Marsden
Journal:  J Neurochem       Date:  1993-01       Impact factor: 5.372

10.  The nucleus basalis of Meynert in neurological disease: a quantitative morphological study.

Authors:  J D Rogers; D Brogan; S S Mirra
Journal:  Ann Neurol       Date:  1985-02       Impact factor: 10.422

View more
  15 in total

Review 1.  Cortical afferent inhibition abnormalities reveal cholinergic dysfunction in Parkinson's disease: a reappraisal.

Authors:  Raffaele Nardone; Francesco Brigo; Viviana Versace; Yvonne Höller; Frediano Tezzon; Leopold Saltuari; Eugen Trinka; Luca Sebastianelli
Journal:  J Neural Transm (Vienna)       Date:  2017-08-12       Impact factor: 3.575

Review 2.  Cortical excitability and neurology: insights into the pathophysiology.

Authors:  Radwa A B Badawy; Tobias Loetscher; Richard A L Macdonell; Amy Brodtmann
Journal:  Funct Neurol       Date:  2012 Jul-Sep

3.  Short-latency afferent inhibition determined by the sensory afferent volley.

Authors:  Aaron Z Bailey; Michael J Asmussen; Aimee J Nelson
Journal:  J Neurophysiol       Date:  2016-05-25       Impact factor: 2.714

Review 4.  Olfaction in Parkinson's disease and related disorders.

Authors:  Richard L Doty
Journal:  Neurobiol Dis       Date:  2011-12-20       Impact factor: 5.996

5.  Interhemispheric inhibition in different phenotypes of progressive supranuclear palsy.

Authors:  M Wittstock; I Pohley; U Walter; A Grossmann; R Benecke; A Wolters
Journal:  J Neural Transm (Vienna)       Date:  2012-08-15       Impact factor: 3.575

Review 6.  Transcranial Magnetic Stimulation for the Assessment of Neurodegenerative Disease.

Authors:  Steve Vucic; Matthew C Kiernan
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

7.  Functional evaluation of central cholinergic circuits in patients with Parkinson's disease and REM sleep behavior disorder: a TMS study.

Authors:  Raffaele Nardone; Jürgen Bergmann; Francesco Brigo; Monica Christova; Alexander Kunz; Martin Seidl; Frediano Tezzon; Eugen Trinka; Stefan Golaszewski
Journal:  J Neural Transm (Vienna)       Date:  2012-08-19       Impact factor: 3.575

8.  Central cholinergic dysfunction in the adult form of Niemann Pick disease type C: a further link with Alzheimer's disease?

Authors:  Fiore Manganelli; Raffaele Dubbioso; Rosa Iodice; Antonietta Topa; Andrea Dardis; Cinzia Valeria Russo; Lucia Ruggiero; Stefano Tozza; Alessandro Filla; Lucio Santoro
Journal:  J Neurol       Date:  2014-02-26       Impact factor: 4.849

Review 9.  Safety of transcranial magnetic stimulation in Parkinson's disease: a review of the literature.

Authors:  Matthew Vonloh; Robert Chen; Benzi Kluger
Journal:  Parkinsonism Relat Disord       Date:  2013-03-07       Impact factor: 4.891

10.  Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson's disease.

Authors:  Fiore Manganelli; Carmine Vitale; Gabriella Santangelo; Chiara Pisciotta; Rosa Iodice; Autilia Cozzolino; Raffaele Dubbioso; Marina Picillo; Paolo Barone; Lucio Santoro
Journal:  Brain       Date:  2009-07-07       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.